Captrust Financial Advisors Trevena Inc Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.41 - $0.63 $82,000 - $126,000	200,000 Added 10526.32%	201,900 $111,000
Q3 2020 Nov 17, 2020	BUY	$1.53 - $3.13 $2,907 - $5,947	1,900 New	1,900 $6,000
Q4 2019 Feb 14, 2020	SELL	$0.62 - $1.06 $1,670 - $2,856	-2,695 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.81 - $1.06 $2,182 - $2,856	2,695 New	2,695 $3,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.